5α-reductase inhibitors impact prognosis of urothelial carcinoma.

Study design not specified in the source record · BMC Cancer · 2020. Source record refreshed; an explanation has not been reviewed.

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Wang CS, Li CC, Juan YS et al.
BMC Cancer · 2020

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.